| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 674127 | 96011001 | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 2 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96011001/96011001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96011001/96011001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30180 | 7980 | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 724274 | 83664 | VIANT POLVO PARA SOLUCION PARA PERFUSION | VIANT POLVO PARA SOLUCION PARA PERFUSION, 10 viales | N/A (más de 4 PA) | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83664/83664_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83664/83664_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 307 | 306 | 2018-12-12 | 1 | 1 | 1 | 2018-12-13 | 2018-12-12 | 1 | 2019-06-28 | View Edit Delete | ||||||||||||
| 725934 | 1181336001 | BUVIDAL 8 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 8 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA, 1 jeringa precargada de 0.16 ml | 8 mg inyectable 0,16 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.16 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336001/1181336001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336001/1181336001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 725935 | 1181336002 | BUVIDAL 16 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 16 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA, 1 jeringa precargada de 0.32 ml | 16 mg inyectable 0,32 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.32 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336002/1181336002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336002/1181336002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 725936 | 1181336003 | BUVIDAL 24 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 24 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA 1 jeringa precargada de 0.48 ml | 24 mg inyectable 0,48 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.48 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336003/1181336003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336003/1181336003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 725938 | 1181336004 | BUVIDAL 32 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 32 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA, 1 jeringa precargada de 0.64 ml | 32 mg inyectable 0,64 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.64 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336004/1181336004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336004/1181336004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 725939 | 1181336005 | BUVIDAL 64 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 64 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA, 1 jeringa precargada de 0.18 ml | 64 mg inyectable 0,18 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.18 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336005/1181336005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336005/1181336005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-10 | 1 | 1 | 1 | 2019-07-11 | 2019-07-10 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 725940 | 1181336006 | BUVIDAL 96 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 96 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA, 1 jeringa precargada de 0.27 ml | 96 mg inyectable 0,27 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.27 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336006/1181336006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336006/1181336006_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 725941 | 1181336007 | BUVIDAL 128 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 128 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA, 1 jeringa precargada de 0.36 ml | 128 mg inyectable 0,36 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.36 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336007/1181336007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336007/1181336007_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 728862 | 85218 | CINFADOL SPRAY 39,2 MG/ML SOLUCIÓN PARA PULVERIZACIÓN CUTÁNEA | CINFADOL SPRAY 39,2 MG/ML SOLUCIÓN PARA PULVERIZACIÓN CUTÁNEA , 1 frasco de 30 ml | 39,2 mg/ml | 68 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85218/85218_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85218/85218_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2020-07-02 | 1 | 1 | 1 | 2020-07-03 | 2020-07-02 | 1 | 2021-10-21 | View Edit Delete | ||||||||||||
| 731855 | 86279 | DICLOKERN SPRAY 39,2 MG/ML SOLUCION PARA PULVERIZACION CUTANEA | DICLOKERN SPRAY 39,2 MG/ML SOLUCION PARA PULVERIZACION CUTANEA, 1 frasco de 30 ml (150 pulverizaciones) | 39,2 mg/ml | 68 | 30 | 26 | 1 frasco de 30 ml (150 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86279/86279_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86279/86279_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2021-10-05 | 1 | 1 | 1 | 2021-10-06 | 2021-10-05 | 1 | 2022-08-22 | View Edit Delete | ||||||||||||
| 757410 | 87925 | COLECALCIFEROL TEVA 25.000 UI CAPSULAS BLANDAS | COLECALCIFEROL TEVA 25.000 UI CAPSULAS BLANDAS , 4 cápsulas | 25.000 UI | 5 | 4 | 43 | 4 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87925/87925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87925/87925_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-07-01 | 1 | 1 | 1 | 2022-07-02 | 2022-07-01 | 1 | 2022-12-14 | View Edit Delete |